Mankind Pharma settles flat post-Q4 announcement
Mankind Pharma Q4 results: The country's fourth-largest pharmaceutical company by domestic sales reported a 50 per cent year-on-year (YOY) rise in Q4 profit helped by lower input costs.
Mankind Pharma share price target: Global brokerage firm Macquarie has maintained an outperform on the counter with a target price of Rs 1,400. Image: Pexels/ Representational image